Back

Diffuse coronary artery disease and effect of implantable cardioverter-defibrillators in patients with non-ischaemic systolic heart failure

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Heart failure: prognosis, outcome Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Christina Byrne

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

9 More presentations in this session

Presentation thumbnail
Predicting cardiac recovery before durable left ventricular assist device implantation in advanced heart failure patients
Doctor S. Drakos (Salt Lake City, US)
Abstract Slides
Presentation thumbnail
Early benefits of empagliflozin in patients with type 2 diabetes with heart failure are not offset by increased adverse events: results from the EMPA-REG OUTCOME trial
Doctor P. Pellicori (Glasgow, GB)
Abstract
Presentation thumbnail
Incidence and prognostic impact of new-onset left bundle branch block in patients with heart failure and reduced ejection fraction
Professor L. Kober (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Improved attitudes of non-cardiologists towards decreased left ventricular ejection fraction after marking "warning" on echocardiography report
Miss Q. Chen (Chengdu, CN)
Abstract
Presentation thumbnail
Prognosis and predictors for left ventricular reverse remodeling in dilated cardiomyopathy
Professor I. Jung (Yongin, KR)

Access the full session

Session thumbnail
Poster Session 3 - Heart failure: prognosis, outcome

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources